MDR Volume Alert - MDR 4.06 McDermott International $MDR

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 3:26 PM

MDR Volume Alert - MDR 4.06 McDermott International $MDR Hit a high of 4.13 Currently 11:15 Last price 4.06 +0.09 +2.27% With a day low of 3.99 and a current volume of 1,489,514.

MDR McDermott International Recent Headline News

McDermott wins subsea contract from Brunei Shell Petroleum
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 7:36AM CST

MDR: 4.07 (+0.10)

McDermott Awarded Significant Multi-year Offshore Installation Contract by Brunei Shell Petroleum
Business Wire - Tue Nov 11, 6:30AM CST
McDermott International, Inc. (NYSE: MDR) ("McDermott" or "the Company"

announced today that it has been awarded a three-year shallow water pipeline contract by Brunei Shell Petroleum Company Sdn. Bhd. ("BSP"

to transport and install pipelines and umbilicals for the Champion and Ampa Fields offshore Brunei. Work is expected to be executed through 2017.
MDR: 4.07 (+0.10)

McDermott International Incurs Wider-than-Expected Q3 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 2:40PM CST
McDermott International (MDR) reported third-quarter 2014 loss of 14 cents per share, wider than the Zacks Consensus Estimate of loss of 10 cents.
PZE: 6.36 (-0.04), BAK: 14.63 (+0.21), MDR: 4.07 (+0.10), MUSA: 59.43 (+0.16)

McDermott International's (MDR) CEO David Dickson on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 9:20PM CST

MDR: 4.07 (+0.10)

McDermott misses by $0.03, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 3:57PM CST

MDR: 4.07 (+0.10)

McDermott International (MDR) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 3:55PM CST

MDR: 4.07 (+0.10)

McDermott Reports Third Quarter 2014 Financial Results
Business Wire - Wed Nov 05, 3:07PM CST
--Solid Backlog, Improved Customer Relations Position the Company for Long-Term Growth
MDR: 4.07 (+0.10)

McDermott Announces Date for Third Quarter 2014 Financial Results and Conference Call
Business Wire - Mon Oct 27, 9:20AM CDT
McDermott International, Inc. (NYSE: MDR) ("McDermott" or the "Company"

announced today that it plans to issue a press release regarding its financial results for the third quarter 2014 on Wednesday, November 5, 2014, after the close of trading on the New York Stock Exchange. The Company has scheduled a conference call related to its third quarter 2014 results on Wednesday, November 5, 2014 at 4:00 p.m. (Central Standard Time).
MDR: 4.07 (+0.10)

Which Stocks Hurt Billionaire Portfolios the Most in 2014?
at The Street - Mon Oct 27, 7:48AM CDT
See the stocks that have performed the worst for 19 billionaires who made their money investing.
BID: 41.60 (+0.15), CBI: 54.99 (+0.44), MDR: 4.07 (+0.10), DLIA: 0.12 (-0.01), EOPN: 6.48 (+0.18), PGEM: 13.07 (+0.05), ENZY: 6.64 (-0.22), GNC: 43.01 (-0.04), AMCC: 6.30 (-0.02), HHC: 147.13 (+1.74), LL: 55.45 (-0.40), VLTC: 1.48 (unch), CZR: 10.97 (-0.57), SNSS: 1.68 (-0.02), TWER: 1.45 (-0.04), SHOS: 14.62 (+0.07), DRYS: 1.43 (-0.04), CREE: 33.90 (+0.23)

The Pullback In Oil Stocks Is Just Another 'Buy Cheap' Opportunity
Hawkinvest - at Seeking Alpha - Fri Oct 24, 9:19AM CDT

MDR: 4.07 (+0.10), SLB: 98.13 (-0.16)

Technical Briefing on Oil and Gas Equipment and Services Equities - McDermott Intl., Halliburton, Superior Energy Services, Cameron Intl., and Penn West Petroleum
PR Newswire - Fri Oct 24, 7:55AM CDT
Investor-Edge has initiated coverage on the following equities: McDermott International Inc. (NYSE: MDR), Halliburton Company (NYSE: HAL), Superior Energy Services Inc. (NYSE: SPN), Cameron International Corporation (NYSE: CAM), and Penn West Petroleum Ltd (NYSE: PWE). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, October 23, 2014, the NASDAQ Composite ended at 4,452.79, up 1.60%, the Dow Jones Industrial Average advanced 1.32%, to finish the day at 16,677.90, and the S&P 500 closed at 1,950.82, up 1.23%. The gains were broad based as eight out of ten sectors ended the session in positive. The S&P 500 Energy Sector Index ended the day at 630.02, up 1.79%, with the index also advancing 3.03% in the previous three trading sessions. Register for your complimentary reports on these five stocks at:
MDR: 4.07 (+0.10), PWE: 4.26 (+0.11), CAM: 58.87 (+0.25), HAL: 53.64 (+0.01), SPN: 24.32 (-0.13)

A Lot Of Potential Upside Remains In Small-Cap Stocks
Hawkinvest - at Seeking Alpha - Wed Oct 22, 3:08PM CDT

MDR: 4.07 (+0.10), BC: 48.60 (-0.17), CNO: 17.95 (-0.15), JGW: 11.39 (-0.17)

McDermott Awarded Second Contract for PETRONAS Bukit Tua Development in East Java, Indonesia
Business Wire - Mon Oct 20, 3:40PM CDT
McDermott International, Inc. (NYSE:MDR) ("McDermott"

announced today that one of its subsidiaries was awarded a transportation, installation and pre-commissioning contract by PC Ketapang II Ltd, a subsidiary of PETRONAS, for the Bukit Tua Development Project in the Ketapang block of East Java, Indonesia. The contract will be included in McDermott's fourth quarter backlog.
MDR: 4.07 (+0.10)

4 Reasons To Buy Stocks Now Before A Strong Year-End Rally
Hawkinvest - at Seeking Alpha - Mon Oct 20, 3:49AM CDT

NBL: 56.16 (-0.07), MDR: 4.07 (+0.10), GT: 25.26 (-0.07), SPY: 203.91 (-0.07), CVX: 118.30 (+0.38)

5 Reasons The Oil Sector Is Due For A Big Rebound
Hawkinvest - at Seeking Alpha - Thu Oct 16, 9:38AM CDT

MDR: 4.07 (+0.10), CVX: 118.30 (+0.38), AXAS: 4.16 (+0.04)

Cash Is King: Here Is How To Take Advantage Of The Big Sell-Off
Hawkinvest - at Seeking Alpha - Wed Oct 15, 7:37AM CDT

MDR: 4.07 (+0.10), CVX: 118.30 (+0.38), EROC: 3.02 (+0.04), FSFR: 10.85 (-0.11)

Market Maker Surveillance Report. XLY, MDR, CS, FIG, CIE, ZNGA, Bearishly Biased Price Friction For Thursday, October 9th 2014
M2 - Fri Oct 10, 4:28AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4573 companies with "abnormal" market making, 961 companies with positive Friction Factors and 4314 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bearish bias) in their stock prices. This means that there was more buying than selling in the stocks and their stock prices dropped. Consumer Discretionary Select Sector SPDR Fund (NYSE:XLY), McDermott International Inc (NYSE:MDR), Capstone Mining Corp (NYSE:CS), Fortress Investment Group LLC (NYSE:FIG), COBALT INTERNATIONAL ENERGY, INCORPORATION (NYSE:CIE), Zynga Inc (NASDAQ:ZNGA). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
MDR: 4.07 (+0.10), FIG: 7.33 (unch), CS: 25.94 (-0.04), XLY: 68.16 (+0.19), ZNGA: 2.69 (+0.21), CIE: 10.48 (+0.29)

Stock to Watch: McDermott International Down 8.8% (MDR)
Comtex SmarTrend(R) - Thu Oct 09, 12:41PM CDT
McDermott International (NYSE:MDR) is one of today's worst performing low-priced stocks, down 8.8% to $4.33 on 1.3x average daily volume. Thus far today, McDermott International has traded 8.9 million shares, vs. average volume of 6.7 million shares per day. The stock has underperformed the Dow (-8.8% to the Dow's -1.6%) and underperformed the S&P 500 (-8.8% to the S&P's -1.6%) during today's trading.
MDR: 4.07 (+0.10)

FMC Technologies Wins Subsea Contract from Wintershall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 08, 9:20AM CDT
The Norwegian unit of FMC Technologies Inc. (FTI) has received a subsea contract from Germany's largest oil and gas producer, Wintershall for development of the Maria field, located offshore Norway.
NOV: 73.02 (-0.50), MDR: 4.07 (+0.10), FTI: 55.89 (+0.03), SPN: 24.32 (-0.13)

National Oilwell Upped to Buy on $3B Share Buyback Plan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 3:45PM CDT
On Oct 4, Zacks Investment Research upgraded global large-cap energy equipment maker National Oilwell Varco Inc. (NOV) to a Zacks Rank #2 (Buy).
NOV: 73.02 (-0.50), MDR: 4.07 (+0.10), OIS: 57.50 (+0.56), SPN: 24.32 (-0.13)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Fluence Energy Hits Legal Snag: Investors Called to Act

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...